论文部分内容阅读
由墨西哥国立自治大学和Bioclon Institute公司共同开发的抗蝎毒药Anascorp于2011年8月4日获美国FDA批准上市,该药为美国首个刺尾蝎属蝎
Anascorp, an anti-scorpion pox jointly developed by the National Autonomous University of Mexico and the Bioclon Institute, was approved by the U.S. FDA on August 4, 2011 and is the first scorpion-spire